AI can move through a chart faster and more consistently than any manual process, and for most of the abstraction workflow, that’s exactly what makes it valuable. The exceptions matter just as much. There are specific situations where AI output should never move forward without a clinical expert checking it first, precisely because getting those particular calls right is what makes the rest of the automation trustworthy enough to rely on. Here are four of them:
1. Resolve Ambiguous or Incomplete Documentation
Clinical documentation is inconsistent by nature. A chart might be missing a value, split across a fax and a scanned image, or written in a way that reads differently depending on the specialty of the person charting it. When the source material itself is unclear, an AI model filling in the gap with its best guess isn’t automation. It’s a guess dressed up as a finding.
This is one of the clearest lines to draw: if the documentation doesn’t clearly support an answer, a clinical expert needs to look at it, not the model. It’s also a narrow slice of any given chart. Most documentation is clear enough for AI to work from directly, which is exactly why the unclear cases stand out and deserve a second look.
2. Apply Registry-Specific Judgment to a Complex Case
Every registry has its own rules for how a specific clinical scenario should be coded or classified, and complex cases rarely fit the textbook example. A model can be excellent at pattern matching and still miss the nuance that determines how a particular case should be categorized under a specific registry’s requirements. That kind of judgment comes from experience with the registry itself, not from a model generalizing across documents.
AI can get a complex case most of the way there. The registry-specific call at the end still belongs to someone who knows that registry.
3. Finalize an Answer Without Surfacing Its Source Evidence
An AI-generated answer without a visible link back to the record it came from asks a reviewer to trust the output blindly. That’s a hard position to defend later, whether the question comes from an auditor, a payer, or an internal quality team. Evidence-linked, traceable outputs aren’t a nice-to-have on top of the answer. They’re what makes the answer reviewable at all.
If an AI system can’t show its work, clinical review isn’t actually possible, no matter how confident the output looks. Done well, this cuts both ways: a system that surfaces the right evidence automatically turns review into minutes of verification instead of hours of searching, which is the entire reason to apply AI to this step in the first place.
4. Move a High-Risk Case Through Without Human Confirmation
Not every case carries the same stakes. Some touch outcomes that affect a small number of data points. Others feed directly into metrics tied to accreditation, reimbursement, or patient safety reporting. The higher the impact of getting something wrong, the more deliberate the review needs to be before that case moves forward, regardless of how well the model performed on similar cases in the past.
Treating every case the same, fast or slow, confident or not, ignores the fact that some mistakes cost more than others. The upside is that a system capable of flagging risk level in the first place is what allows review time to go where it actually matters, instead of being spread evenly across cases that don’t need it.
Why Human Oversight Matters in Healthcare AI
In most industries, an AI system that’s wrong occasionally is a minor cost of doing business. In healthcare registry data, the same kind of error can ripple into accreditation decisions, reimbursement, and the credibility of the quality metrics a health system reports on. The scale AI brings to this work is exactly what makes it worth getting the exceptions right. Removing hours of manual search and comparison from a quality team’s workload only pays off if the handful of cases that need a closer look actually get one.
How Prodigy ™ Builds In Trust
Prodigy ™ is built around that distinction. Most of a chart moves through AI-powered abstraction quickly and reliably, which is where the real time savings come from. Anything ambiguous, registry-specific, or high-impact gets routed to MRO’s clinical experts for review, backed by evidence linked directly to the source record. The goal isn’t to slow automation down. It’s to make sure the two work together: AI covering the ground it covers well, and clinical judgment applied exactly where it’s needed.
Building Trust in Healthcare AI Through Clinical Review
None of these four situations are arguments against AI in healthcare. They’re a description of where the boundary needs to sit so the rest of the automation can be trusted. A system that handles the bulk of the work quickly and knows exactly when to defer to a clinical expert is more valuable than one that tries to resolve everything on its own, no matter how good its track record looks on paper.
FAQ: AI and Clinical Review in Healthcare
What should healthcare AI never do without clinical review?
Four situations stand out: resolving ambiguous or incomplete documentation, applying registry-specific judgment to a complex case, finalizing an answer without surfacing the source evidence behind it, and moving a high-risk case forward without human confirmation.
Why can’t AI resolve ambiguous clinical documentation on its own?
When source documentation is unclear or incomplete, any answer the model produces is a best guess rather than a finding grounded in evidence. Clinical judgment is needed to interpret what the documentation actually supports.
Why does registry-specific judgment require clinical review?
Each registry has its own rules for classifying complex cases, and that nuance typically comes from direct experience with the registry rather than general pattern recognition across documents.
Why does an AI-generated answer need linked source evidence?
Without a visible link to the record it came from, an answer can’t be verified or defended later, whether the question comes from an auditor, a payer, or an internal quality review.
Does higher-risk data always need more review than lower-risk data?
Yes. Cases tied to outcomes like accreditation, reimbursement, or patient safety reporting carry higher consequences if something is wrong, which is why they warrant more deliberate review regardless of how a model has performed on similar cases in the past.